Clinical Trial Update: Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects [Phase 2, Phase 3]

View source ↗

Summary

This document reports a completed Phase 2/3 trial evaluating the efficacy and safety of the ALK HDM Tablet in subjects with asthma related to house dust mite al…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ALK HDM Tablet

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Asthma | Phase 2, Phase 3 | Status: COMPLETED